Actinoplanes utahensis

Actinoplanes utahensis is a species of bacteria and a source of the drug acarbose, an alpha-glucosidase inhibitor used in the treatment of diabetes mellitus.

Actinoplanes utahensis
Scientific classification Edit this classification
Domain: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Micromonosporales
Family: Micromonosporaceae
Genus: Actinoplanes
Species:
A. utahensis
Binomial name
Actinoplanes utahensis
Couch 1963 (Approved Lists 1980)[1]
Type strain
ATCC 14539
DSM 43147
IFO 13244
JCM 3122
NBRC 13244
NRRL B-16727
VKM Ac-674

Description

A. utahensis are irregular in size and shape. They form sporangia which are 5 to 18 micrometers in diameter, and contain spores arranged in irregular coils. A. utahensis are motile by way of a number of flagella at one end.[2]

History

A. utahensis was originally identified by John Couch from soils collected from Salt Lake City's Liberty Park as well as along U.S. Route 40 in Nevada.[1]

References

  1. "Some New Genera and Species of the Actinoplanaceae". Journal of the Elisha Mitchell Scientific Society. 79: 69. May 1963. Retrieved 15 October 2017.
  2. Vobis G, Schafer J, Kampfer P (14 September 2015). "Actinoplanes". In Whitman WB (ed.). Bergey's Manual of Systematics of Archaea and Bacteria. John Wiley & Sons. pp. 1–41. doi:10.1002/9781118960608.gbm00139. ISBN 9781118960608.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.